Anning He

433 total citations
13 papers, 386 citations indexed

About

Anning He is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Anning He has authored 13 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Genetics. Recurrent topics in Anning He's work include Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (4 papers) and Cancer-related Molecular Pathways (3 papers). Anning He is often cited by papers focused on Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (4 papers) and Cancer-related Molecular Pathways (3 papers). Anning He collaborates with scholars based in China, United States and Sweden. Anning He's co-authors include W P Bennett, Monica Hollstein, Ilja Küsters, Robert A. Metcalf, David P. Lane, B F Trump, Shoutian Zhu, Judith A. Welsh, James H. Resau and Xinyu Zheng and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cancer Letters and International Journal of Oncology.

In The Last Decade

Anning He

13 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anning He China 7 204 138 120 59 57 13 386
Xiong‐Zhi Wu China 12 109 0.5× 190 1.4× 58 0.5× 41 0.7× 60 1.1× 15 452
Takefumi Katsuki Japan 11 184 0.9× 167 1.2× 66 0.6× 45 0.8× 28 0.5× 29 405
Rami G. Azrak United States 14 175 0.9× 280 2.0× 29 0.2× 32 0.5× 99 1.7× 24 478
Freya A. Goumas Germany 7 302 1.5× 164 1.2× 44 0.4× 51 0.9× 27 0.5× 9 501
Fanming Kong China 12 180 0.9× 226 1.6× 62 0.5× 24 0.4× 113 2.0× 61 515
Kurt Buchegger Chile 11 135 0.7× 262 1.9× 72 0.6× 93 1.6× 61 1.1× 27 458
Andres I. Roig United States 10 166 0.8× 262 1.9× 53 0.4× 87 1.5× 42 0.7× 13 504
Xiangdong Cheng China 13 161 0.8× 180 1.3× 49 0.4× 24 0.4× 88 1.5× 42 470
Alexander von Rücker Germany 10 134 0.7× 193 1.4× 26 0.2× 66 1.1× 94 1.6× 19 453
Xinshu Dong China 15 155 0.8× 418 3.0× 42 0.3× 90 1.5× 35 0.6× 30 594

Countries citing papers authored by Anning He

Since Specialization
Citations

This map shows the geographic impact of Anning He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anning He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anning He more than expected).

Fields of papers citing papers by Anning He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anning He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anning He. The network helps show where Anning He may publish in the future.

Co-authorship network of co-authors of Anning He

This figure shows the co-authorship network connecting the top 25 collaborators of Anning He. A scholar is included among the top collaborators of Anning He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anning He. Anning He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Liu, Ning, et al.. (2018). Low dose Emodin induces tumor senescence for boosting breast cancer chemotherapy via silencing NRARP. Biochemical and Biophysical Research Communications. 505(4). 973–978. 30 indexed citations
2.
Jiang, Haiyang, Lei Zhao, Anning He, et al.. (2015). Tanshinone IIA enhances bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in nuclei and mitochondria. Oncology Reports. 34(3). 1487–1493. 4 indexed citations
3.
Zhang, Mingdi, Hui Xue, Xiaopeng Cai, et al.. (2015). Emodin induces apoptosis of human breast cancer cells by modulating the expression of apoptosis-related genes. Oncology Letters. 10(5). 2919–2924. 53 indexed citations
4.
5.
6.
Xue, Hui, Yangchao Chen, Xiaopeng Cai, et al.. (2013). The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells. Anti-Cancer Drugs. 24(9). 937–944. 11 indexed citations
7.
Ma, Shuai, Zhi Zhu, Anning He, et al.. (2012). Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo. Cancer Letters. 328(1). 95–103. 15 indexed citations
8.
Zhu, Zhi, et al.. (2012). Conditionally replicating adenovirus SG500-expressed mutant Dm-dNK gene for breast cancer therapy. International Journal of Oncology. 41(6). 2175–2183. 2 indexed citations
9.
10.
Zhu, Zhi, Lei Zhao, Anning He, et al.. (2010). Retrovirus-mediated Drosophila melanogaster multisubstrate deoxyribonucleoside kinase gene therapy of gastric cancer cells in vitro and in vivo.. PubMed. 30(7). 2641–9. 2 indexed citations
11.
Ke, Jia, Bin Xu, Anning He, et al.. (2010). Effects of MK-801, taurine and dextromethorphan on neurotoxicity caused by manganese in rats. Toxicology and Industrial Health. 26(1). 55–60. 10 indexed citations
12.
Hollstein, Monica, Helen Cawley, W P Bennett, et al.. (1996). Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors.. PubMed. 56(21). 4917–21. 64 indexed citations
13.
Bennett, W P, Monica Hollstein, Robert A. Metcalf, et al.. (1992). p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.. PubMed. 52(21). 6092–7. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiong‐Zhi Wu Breakdown of academic impact, for papers by Takefumi Katsuki Breakdown of academic impact, for papers by Rami G. Azrak Breakdown of academic impact, for papers by Freya A. Goumas Breakdown of academic impact, for papers by Fanming Kong Breakdown of academic impact, for papers by Kurt Buchegger Breakdown of academic impact, for papers by Andres I. Roig Breakdown of academic impact, for papers by Xiangdong Cheng Breakdown of academic impact, for papers by Alexander von Rücker Breakdown of academic impact, for papers by Xinshu Dong
Rankless by CCL
2026